# PRP Exosomes Therapy for Erectile Dysfunction

> **NCT07124871** · PHASE2 · RECRUITING · sponsor: **Institute for the Study of Urological Diseases, Greece** · enrollment: 30 (estimated)

## Conditions studied

- Erectile Dysfunction Due to Arterial Insufficiency

## Interventions

- **BIOLOGICAL:** PRP-derived exosomes injection

## Key facts

- **NCT ID:** NCT07124871
- **Lead sponsor:** Institute for the Study of Urological Diseases, Greece
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-02
- **Final completion:** 2026-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07124871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07124871, "PRP Exosomes Therapy for Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07124871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*